An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Virginia Board Advances Rulemaking to Restore ABA Certification Pathway
Last year, the Virginia Board of Audiology and Speech-Language Pathology finalized regulatory changes intended to streamline licensure by removing the direct linkage between certification and…
Sleep Routines and Tiredness in US Children
Do you work or interact with children? Do you any of them complain of being tired? If so, you may be interested in a recently-published…
AAA Foundation Highlights from AAA 2026
The AAA Foundation made a strong impact at AAA 2026 in San Antonio, supporting key sessions and events that advanced learning, collaboration, and community across…


